Uncategorized

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

Positive CHMP opinion for CabometyxTM (cabozantinib)
Aepodia integrates Ipsen’s R&D Campus in Paris-Saclay biotechnology hub
Celebration of Ipsen Canadian Headquarters Grand Opening in Mississauga, Ontario
Opening of a new manufacturing facility in Russia
Achievements in 2014 and future prospects
A new R&D center in Cambridge (USA)
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023